- idUS
- Listar por autor
Listar por autor "Rodríguez de Fonseca, Fernando"
Mostrando ítems 1-4 de 4
-
Artículo
Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease
Fernández Espejo, Emilio; Rodríguez de Fonseca, Fernando; Gavito, Ana Luisa; Córdoba Fernández, Antonio; Chacón, José; Martín de Pablos, Ángel (MDPI, 2022-05-30)Background: Myeloperoxidase (MPO) and advanced oxidation protein products, or AOPP (a type of MPO-derived chlorinated ...
-
Artículo
Native α-synuclein, 3-nitrotyrosine proteins, and patterns of nitro-α-synuclein-immunoreactive inclusions in saliva and submandibulary gland in parkinson’s disease
Fernández-Espejo, Emilio; Rodríguez de Fonseca, Fernando; Suárez, Juan; Tolosa, Eduardo; Vilas, Dolores; Aldecoa, Iban (MDPI, 2021-05-01)Background. Salivary α-synuclein (aSyn) and its nitrated form, or 3-nitrotyrosine-αsynuclein (3-NT-αSyn), hold promise as ...
-
Artículo
Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ́s disease
Fernández-Espejo, Emilio; Gavito, Ana L.; Suárez, Juan; Tolosa, Eduardo; Vilas, Dolores; Aldecoa, Iban; Berenguer, Juan; Córdoba Fernández, Antonio; Damas Hermoso, Fátima; Rodríguez de Fonseca, Fernando (Elsevier BV, 2022)Background: ATP13A2 holds promise as biomarker for Parkinsońs disease (PD). No study has examined how salivary ATP13A2 ...
-
Patente. Invención
Uso de derivados de sulfamidas como neuroprotectores
Rodríguez de Fonseca, Fernando; Suárez Pérez, Juan; Romero Cuevas, Miguel; Fernández-Espejo, Emilio; Goya Laza, María Pilar (Oficina Española de Patentes y Marcas (OEPM), 2013-09-04)Uso de derivados de sulfamidas como neuroprotectores. La presente invención se refiere al uso de un grupo de derivados ...